Wed, May 19, 2021
Tue, May 18, 2021
Mon, May 17, 2021
Fri, May 14, 2021
Thu, May 13, 2021
Wed, May 12, 2021
Tue, May 11, 2021
Mon, May 10, 2021

Vikram Purohit Maintained (TBPH) at Buy with Decreased Target to $28 on, May 13th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-28-on-may-13th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $30 to $28 on, May 13th, 2021.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $39 on, Wednesday, May 5th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, May 5th, 2021

Publication Contributing Sources